Comparison of Interleukin-6 Levels After Rectal Irrigation With Metronidazole and Normal Saline Versus Normal Saline Alone in Male Wistar Rats With a Hirschsprung-Associated Enterocolitis Model
DOI:
https://doi.org/10.26555/eshr.v8i2.16452Keywords:
Enterocolitis, Rectal irrigation, Hirschsprung disease, Inflammation, Interleukin- 6, MetronidazoleAbstract
Background: Hirschsprung-Associated Enterocolitis (HAEC) is a serious complication of Hirschsprung disease characterized by intestinal inflammation. Rectal irrigation with systemic antibiotics is the standard management, but efficacy remains limited. Metronidazole, an effective anaerobic antibiotic, has immunomodulatory properties that may reduce inflammation. This study evaluates whether topical metronidazole combined with normal saline irrigation reduces IL-6 levels more effectively than saline alone.
Method: An experimental study using 20 male Wistar rats (2-3 months, 250-300g) was conducted. HAEC model was induced using benzalkonium chloride (BAC) 0.1% applied topically to the sigmoid colon. Rats were randomized into two groups: Control group (K) receiving rectal irrigation with normal saline 0.9% (10 mL/kg/day, once daily), and Treatment group (P) receiving combination irrigation with metronidazole 7.5 mg/kg/day plus normal saline 10 mL/kg/day (twice daily). Both interventions began on day 7 post-induction and continued until day 14. Serum IL-6 levels were measured by ELISA on day 14. Data were analyzed using independent samples t-test.
Results: The combination group demonstrated a mean IL-6 level of 4.47 ± 1.54 pg/mL versus 5.63 ± 2.04 pg/mL in the saline-only group (mean difference -1.15 pg/mL, 95% CI: -2.85 to 0.54; t = -1.430, df = 18, p = 0.170). Normal distribution was confirmed in both groups (Shapiro-Wilk: W = 0.904, p = 0.243 and W = 0.879, p = 0.126, respectively), and homogeneity of variance was confirmed by Levene’s test (F = 0.043, p = 0.837).
Conclusion: Combination irrigation with metronidazole demonstrated a numerically lower mean IL-6 level compared with saline alone (4.47 ± 1.54 vs. 5.63 ± 2.04 pg/mL; Cohen’s d = 0.64); however, this difference was not statistically significant under the current experimental conditions (p = 0.170). Given the unequal irrigation frequency between groups and the limited statistical power of this pilot study, these findings should be regarded as hypothesis-generating rather than evidence of therapeutic efficacy, warranting larger, adequately powered trials with equal irrigation frequency and longer intervention duration.
References
Coran AG, Adzick NS, Krummel TM. Pediatric Surgery. 7th ed. Elsevier; 2012.
Dolgin SE, Hamner CE. Surgical Care of Major Newborn Malformations. 2012.
Puri P, Nakamura H. Epidemiology and clinical characteristics of Hirschsprung’s disease. In: Puri P, ed. Hirschsprung’s Disease and Allied Disorders. Springer; 2019:167-174. doi:10.1007/978-3-030-15647-3
Lewit RA, Kuruvilla KP, Fu M, Gosain A. Current understanding of Hirschsprung-associated enterocolitis: Pathogenesis, diagnosis and treatment. Semin Pediatr Surg. 2022;31(2):151162. doi:10.1016/j.sempedsurg.2022.151162
Gershon MD, Rodriguez L, Arbizu RA. Hirschsprung’s disease associated enterocolitis: A comprehensive review. World J Clin Pediatr. 2023;12(3):68-76. doi:10.5409/wjcp.v12.i3.68
Hagens J, Reinshagen K, Tomuschat C. Prevalence of Hirschsprung-associated enterocolitis in patients with Hirschsprung disease. Pediatr Surg Int. 2022;38(1):3-24. doi:10.1007/s00383-021-05020-y
Lewit RA, Kuruvilla KP, Fu M, Gosain A. Current understanding of Hirschsprung-associated enterocolitis: Pathogenesis, diagnosis and treatment. Semin Pediatr Surg. 2022;31(2):151162. doi:10.1016/j.sempedsurg.2022.151162
Lewit RA, Veras LV, Cowles RA, Gosain A. Reducing underdiagnosis of Hirschsprung-associated enterocolitis: A novel scoring system. J Surg Res. 2021;261:253-260. doi:10.1016/j.jss.2021.01.026
Gosain A, Barlow-Anacker AJ, Erickson CS. Impaired cellular immunity in the murine neural crest conditional deletion of endothelin receptor-B model of Hirschsprung’s disease. PLoS ONE. 2015;10(6):e0128822. doi:10.1371/journal.pone.0128822
Li S, Zhang Y, Li K. Update on the pathogenesis of the Hirschsprung-associated enterocolitis. Int J Mol Sci. 2023;24(5):4602. doi:10.3390/ijms24054602
Chantakhow S, Khorana J, Tepmalai K. Alterations of gut bacteria in Hirschsprung disease and Hirschsprung-associated enterocolitis. Microorganisms. 2021;9(11):2241. doi:10.3390/microorganisms9112241
Gosain A, Frykman PK, Cowles RA. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517-521. doi:10.1007/s00383-017-4065-8
Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50(Suppl 1):S16-S23. doi:10.1086/647939
Ceruelos E, Camacho A, Orueta R. Adverse effects of metronidazole. Med Clin (Barc). 2019;152(12):474-485.
Bennibol E, Kim M, Sanchez A. Elevated expression of IL-6 and TNF-α in segments of Hirschsprung disease-associated enterocolitis. J Pediatr Surg. 2023;58(4):815-821.
Keck B, Feurle A, Illing S. IL-6 and IL-1β mediated intestinal inflammation in Hirschsprung-associated enterocolitis. J Pediatr Surg. 2021;56(8):1439-1447.
Keck B, Feurle A, Illing S. IL-6 and IL-1β mediated intestinal inflammation in Hirschsprung-associated enterocolitis. J Pediatr Surg. 2021;56(8):1439-1447.
Gosain A, Brinkman AS. Hirschsprung’s associated enterocolitis. Curr Opin Pediatr. 2015;27(3):364-369. doi:10.1097/MOP.0000000000000210
Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014;2(4):288-294. doi:10.1158/2326-6066.CIR-14-0022
Ji H, Liu Y, Ye F. Regulatory role of neural-immune axis in Hirschsprung disease. Front Immunol. 2023;14:1287906. doi:10.3389/fimmu.2023.1287906
Alhendi A, Naser SA. The dual role of interleukin-6 in Crohn’s disease pathophysiology. Front Immunol. 2023;14:1295230. doi:10.3389/fimmu.2023.1295230
Lu C, Xie H, Li H. Feasibility and efficacy of home rectal irrigation in neonates and early infancy with Hirschsprung disease. Pediatr Surg Int. 2019;35(11):1245-1253. doi:10.1007/s00383-019-04552-8
Marty TL, Seo T, Matlak ME, Sullivan JJ, Black RE, Johnson DG. Rectal irrigations for the prevention of enterocolitis in Hirschsprung’s disease. J Pediatr Surg. 1995;30(3):319-322. doi:10.1016/0022-3468(95)90047-0
Alkhashab MM, Abdalfattah DM, Al-Rawee RY. Metronidazole gel foam influence on salivary tumor necrosis factor and interleukin-6 with lower third molar extraction (randomized control clinical study). Oral Health Dent Sci. 2020;4(3):1-4.
Kazempour M, Izadi H, Chouhdari A, Rezaeifard M. Anti-inflammatory effect of metronidazole in hospitalized patients with pneumonia due to COVID-19. Iran J Pharm Res. 2021;20(3):532-540. doi:10.22037/ijpr.2021.114567.14917
Sato Y, Pringle KC, Soper RT. Rectal biopsy as a diagnostic tool for enterocolitis associated with Hirschsprung’s disease. J Pediatr Surg. 1978;13(2):155-162.
Keck B, Feurle A, Illing S. IL-6 and IL-1β mediated intestinal inflammation in Hirschsprung-associated enterocolitis. J Pediatr Surg. 2021;56(8):1439-1447.
Dingsdag SA, Hunter N. Metronidazole: An old dog, new tricks? Future Microbiol. 2018;13(9):1027-1039. doi:10.2217/fmb-2018-0059
Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50(Suppl 1):S16-S23. doi:10.1086/647939
Pierre JF, Barlow-Anacker AJ, Erickson CS. Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung’s disease. J Pediatr Surg. 2014;49(8):1242-1251. doi:10.1016/j.jpedsurg.2014.02.049
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Agung Aditya Arnaya, Kadek Deddy Ariyanta, Ketut Sudartana
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with ESHR agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
